{
  "id": 16968775,
  "title": "Glaxo shares slump amid concerns over its vaccine pipeline of new drugs as patent losses loom",
  "url": "https://urgent.news/2026/10/28/glaxo-shares-slump-amid-concerns-over-its-vaccine-pipeline-of-new",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-28T22:03:58.000Z",
  "source": {
    "name": "This Is Money",
    "slug": "this-is-money",
    "url": "https://www.thisismoney.co.uk/money/markets/article-16246859/Glaxo-shares-slump-amid-concerns-vaccine-pipeline-new-drugs-patent-losses-loom.html?ns_mchannel=rss&ns_campaign=1490&ito=1490"
  },
  "original_language": "en",
  "account": null,
  "summary": "The pharmaceutical giant reported beat third-quarter sales and profit expectations, driven by a 15% rise in demand for its specialty HIV and respiratory medicines.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}